The Application of Robotics to Aseptic Environmental Surface Monitoring - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Application of Robotics to Aseptic Environmental Surface Monitoring
This article presents a study of an aseptic environmental monitoring system for surface contamination at critical areas using a robot.


Pharmaceutical Technology


Methodology


Table I: Swab sampling parameters.
Two species of microorganisms, Micrococcus luteus NBRC13867, a vegetative Gram-positive coccus, and Bacillus atrophaeus ATCC 9372, a spore, were selected as test organisms. These microorganisms were selected because they are representative of common human associated organisms, which are often Gram-positive cocci, and also of spore-bearing organisms that may enter on supplies or apparatus that might not have been properly decontaminated. Small stainless-steel coupons were used as carriers of the test microorganisms. The carrier surface was polished to 320 grit and a predetermined number of CFU was inoculated on the polished surface of the carrier. A metal surface finish of 320 grit was chosen because it is broadly representative of a level of polish applied to critical surfaces of the filing and component feed machinery. In general, the surfaces of isolator enclosures are given a similar surface finish. The inoculated carriers were air-dried under HEPA-filtered uni-directional airflow.


Table II: Dry swab efficacy (robot).
After some preliminary experimentation with commercial swabs (Becton, Dickinson and Company in Franklin Lakes, NJ, and ITW Texwipe in Mahwah, NJ), the authors developed specifications for a swab apparatus that was then custom made. After test operation, all swab rods were incubated in Soya Bean Casein Digest broth at 30° C for two weeks and then inspected for the presence of colonies indicative of microbial growth. The relatively long incubation time was chosen to ensure maximal recovery.

Swab sampling conditions


Table III: Wet swab efficiency with distilled water as wetting agent (robot).
The swab sampling experiments were conducted using the test parameters listed in Table I. The authors hypothesized that when the wet-swab method was used, the microbial recovery rate might vary as a function of moisture content in the swab tip. Therefore, two moisture levels were evaluated in this study. To ensure a very moist swab in one study, the tip was moistened immediately before use. To achieve a higher moisture level, swabs were soaked one day before use to ensure the full saturation of the swab tip.

Results


Table IV:Wet swab efficiency with distilled water 10.1%Tween80 as wetting agent (robot) .
When the dry-swab method was used, the observed recovery (CFU) correlated well with the inoculation level for B. atrophaeus spores. No M. luteus colonies were observed after incubation. A high swabbing force resulted in better recovery of spores (see Table II). In addition, the wet method, in which distilled water was used as the wetting agent, gave much better recovery efficiency than was observed using dry swabs. Sufficient time for absorption of water into the swab tip resulted in more efficient recovery. In addition, recovery efficiency was significantly affected by the speed at which the swab moved across the surface being sampled (see Table III).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here